146 results on '"Weiskranz, Lawrence"'
Search Results
2. Critical Acute Akinesia in Parkinson’s Disease Patients Concomitant with Additional Precipitating Factors Other Than Treatment Withdrawal: A Possible Lethal Complication
3. LRRK2 (Leucine-Rich Repeat Kinase 2) Gene on PARK8 Locus in Families with Parkinsonism
4. Novel Therapeutic Target in PD: Experimental Models
5. Evidence That Amyloid Pathology Progresses in a Neurotransmitter-Specific Manner
6. Neurotransmitter and Neurotrophic Factor-Secreting Cell Line Grafting for the Treatment of Parkinson’s Disease
7. Biomarkers for Early Detection of Parkinson’s Disease: An Essential Challenge
8. Allosteric Potentiators of Neuronal Nicotinic Cholinergic Receptors: Potential Treatments for Neurodegenerative Disorders
9. Current Problems and Strategies in Motor Rehabilitation for Parkinson’s Disease
10. Dissociation Between the Potent β-Amyloid Protein Pathway Inhibition and Cholinergic Actions of the Alzheimer Drug Candidates Phenserine and Cymserine
11. Role of b-Amyloid in the Pathophysiology of Alzheimer’s Disease and Cholinesterase Inhibition: Facing the Biological Complexity to Treat the Disease
12. Expression of Acetylcholinesterase in Alzheimer’s Disease Brain: Role in Neuritic Dystrophy and Synaptic Scaling
13. Neurogenetics in Parkinson's Disease
14. Cortical Cholinergic Lesion Causes Aβ Deposition: Cholinergic-Amyloid Fusion Hypothesis
15. Rationale for Glutamatergic and Cholinergic Approaches for the Treatment of Alzheimer’s Disease
16. Cellular Membranes as Targets in Amyloid Oligomer Disease Pathogenesis
17. In Vivo Targeting of Amyloid Plaques Via Intranasal Administration of Phage Anti-β-Amyloid Antibodies
18. Impaired DNA Repair Systems: Generation of Mitochondrial Dysfunction and Increased Sensitivity to Excitotoxicity
19. Frequency and Relation of Argyrophilic Grain Disease and Thorn-Shaped Astrocytes in Alzheimer’s Disease
20. Up-regulation of the α-Secretase Pathway
21. Enhanced Activation of NF-κB Signaling by Apolipoprotein E4
22. Co-expression of FTDP-17 Human Tau and GSK-3ß (or APPSW) in Transgenic Mice: Induction of Tau Polymerization and Neurodegeneration
23. Expression of Wnt Receptors, Frizzled, in Rat Neuronal Cells
24. Cell Models of Tauopathy
25. Pleiotropic Effects of Apolipoprotein E in Dementia: Influence on Functional Genomics and Pharmacogenetics
26. Physiological Processing of the Cellular Prion Protein and βAPP: Enzymes and Regulation
27. Intraneuronal Aβ and Alzheimer’s Disease
28. Neuroprotective Effects of Trophic Factors and Natural Products: Involvement of Multiple Intracellular Kinases
29. Decreased ProBDNF: The Cause of Alzheimer’s-Associated Neurodegeneration and Cognitive Decline?
30. Oral Aβ Vaccine Using a Recombinant Adeno-Associated Virus Vector in an Alzheimer’s Disease Mouse Model
31. Stem Cell Therapy in Alzheimer’s Disease
32. Shift in the Balance of TRKA and ProNGF in Prodromal Alzheimer ’s Disease
33. Glycosaminoglycans and Analogs in Neurodegenerative Disorders
34. Two Hits and You’re Out? A Novel Mechanistic Hypothesis of Alzheimer Disease
35. Vascular Risk Factors and Risk for Alzheimer’s Disease and Mild Cognitive Impairment: Population-Based Studies
36. Prospective Role of Glycosaminoglycans in Apoptosis Associated with Neurodegenerative Disorders
37. Cholesterol Transport and Production in Alzheimer’s Disease
38. Clinical Features and Treatment of Dementia Associated With Parkinson’s Disease
39. Biomarkers for Alzheimer’s Disease and Parkinson’s Disease
40. Cholesterol and Aβ Production: Methods for Analysis of Altered Cholesterol De Novo Synthesis
41. Alzheimer’s Disease Neuroimaging Initiative
42. Bioluminescent Imaging of Excitotoxic and Endotoxic Brain Injury in Living Mice
43. Redox Proteomics Identification of Oxidatively Modified Proteins in Alzheimer’s Disease Brain and in Brain from a Rodent Model of Familial Parkinson’s Disease: Insights into Potential Mechanisms of Neurodegeneration
44. Neuroinflammation in Early Stages of Alzheimer’s Disease and Parkinson’s Disease
45. Alzheimer’s Disease, Parkinson’s Disease, and Frontotemporal Dementias: Different Manifestations of Protein Misfolding
46. Role of Oxidative Insult and Neuronal Survival in Alzheimer’s and Parkinson’s Diseases
47. Dissecting the Biochemical Pathways Mediated by Genes Implicated in Parkinson’s Disease: Induction of DJ-1 Expression in A30P α-Synuclein Mice
48. Microglia Activation and Gene Expression of Cytokines in Parkinson’s Disease
49. Nitric Oxide Signaling Modulates the Responsiveness of Striatal Medium Spiny Neurons to Electrical Stimulation of the Substantia Nigra : Striatal Nitrergic Signaling
50. Spontaneous Formation of Lewy Bodies in a Rodent
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.